BUZZ-Australia's Starpharma soars on drug delivery license with AstraZeneca
** Dendrimer products developer Starpharma Holdings Ltd jumps as much as 31 pct
** Company signs licensing agreement with UK-based AstraZeneca PLC (NYSE: AZN - news)
** Adds agreement is for development and commercialisation of an AstraZeneca oncology compound, using Starpharma's DEP drug delivery technology
** Stock is the top percentage gainer on the ASX All Ordinaries Index in early trading
** About 748,705 shares change hands in early trading, compared with 30-day average of 144,459.40 shares (Reuters Messaging: ruchira.k.thomsonreuters.com@reuters.net)